CNSP stock forecast
Our latest prediction for CNS Pharmaceuticals, Inc.'s stock price was made on the Aug. 24, 2020 when the stock price was at 2.16$.
In the short term (2weeks), CNSP's stock price should outperform the market by 5.96%. During that period the price should oscillate between -10.96% and +23.55%.
In the medium term (3months), CNSP's stock price should outperform the market by 2.06%. During that period the price should oscillate between -43.68% and +48.14%.Get email alerts
Create a solid portfolio with CNSP
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.50$ per share.
The book value per share is 0.23$
Three months stock forecastAug. 24, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|